Opening Eyes and Rising Up For Blindness Earlier this month CRBF was able to share our mission at Novartis Pharmaceutical in Boston. Novartis now owns the […]
Patients Now Have An Opportunity To Drive CRB1 Research and Advocacy The latest development in moving research forward for CRB1 LCA/RP retinal disease involves a collaborative […]